Almac appoints Charlie Morris as VP new products and services in clinical technologies division

Charlie Morris (pictured) has joined the Almac Group's clinical technologies division as VP of new products and services.

According to the company, which provides services to the pharma industry, he will oversee the development of its IXRS technology to manage patients, supplies, and clinical trial data.

Morris joins Almac from Princeton Financial Systems where he served as chief technology officer for more than ten years.

Prior to this, he served as director of applications development at Telescan, building and implementing teleradiology systems. He began his career in military contracts where he developed flight simulation, anti-submarine warfare, and naval intelligence systems.

Jim Murphy, president of Almac's clinical technologies unit, said: “Given [Morris'] breadth of system development leadership experience, we are highly confident in his ability to align the new products and services department to support accelerated innovation of Almac's technology.

“We welcome Charlie to Almac and know he will have a profound impact on the expansion of our technology offerings and client relationships.”